Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Disorders of Hemostasis01:24

Disorders of Hemostasis

756
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
756

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Venous Intervention in Children: Current Practice and Controversies.

Cardiovascular and interventional radiology·2026
Same author

Association of Patient-Reported Outcomes with Hemophilia A Inhibitor Status and Treatment Product Type.

Journal of clinical medicine·2026
Same author

Inferior Vena Cava Filter Placements and Retrieval in Pediatric Patients: Experience of Four U.S. Pediatric Hospitals.

AJR. American journal of roentgenology·2025
Same author

Endovascular Management of Pediatric Deep Venous Thrombosis.

Seminars in interventional radiology·2025
Same author

Risk factors for joint bleeding in severe hemophilia A and B: analysis of the Community Counts longitudinal surveillance cohort.

Blood vessels, thrombosis & hemostasis·2025
Same author

A Naturally Occurring Gain-of-Function Mutation in Factor VIII.

The New England journal of medicine·2025
Same journal

Treatment of Coagulopathy.

Techniques in vascular and interventional radiology·2026
Same journal

Acute Kidney Injury for the Interventional Radiologist: A Review.

Techniques in vascular and interventional radiology·2026
Same journal

Acute Management of Dysrhythmias.

Techniques in vascular and interventional radiology·2026
Same journal

An Approach to Airway Management and Acute Respiratory Failure.

Techniques in vascular and interventional radiology·2026
Same journal

Emergency Preparedness in the Vascular and Interventional Radiology Suite-An Overview.

Techniques in vascular and interventional radiology·2026
Same journal

Management of Acute Hemorrhage and Damage-Control Resuscitation: Critical Care Concepts for Vascular Interventional Radiologists.

Techniques in vascular and interventional radiology·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2025

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

743

Anticoagulation in Pediatric Patients.

Marilyn J Manco-Johnson1, Aparna Annam2, Timothy Schardt3

  • 1Department of Pediatrics, Hemophilia & Thrombosis Center, University of Colorado Anschutz Medical Campus, Aurora, CO.

Techniques in Vascular and Interventional Radiology
|August 21, 2024
PubMed
Summary
This summary is machine-generated.

Pediatric antithrombotic agents, including anticoagulants and antiplatelet drugs, are increasingly used. This review details their mechanisms, safety, and dosing for children.

Keywords:
adolescentsanticoagulationchildreninfantsthrombolysisthrombosis

More Related Videos

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

519
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

950

Related Experiment Videos

Last Updated: Jun 15, 2025

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

743
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

519
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

950

Area of Science:

  • Pediatric Pharmacology
  • Hematology
  • Cardiovascular Medicine

Background:

  • Antithrombotic agent use is rising in pediatric populations.
  • Increased inclusion in clinical trials yields more safety and efficacy data for children.
  • Agents include anticoagulants (indirect, direct thrombin/Factor Xa inhibitors) and antiplatelet therapies.

Purpose of the Study:

  • To review antithrombotic agents used in pediatric patients.
  • To detail mechanisms of action, administration, clearance, and half-life.
  • To discuss anticoagulation in thrombolytic therapy.

Main Methods:

  • Literature review of antithrombotic agents in current pediatric use.
  • Analysis of drug classes, mechanisms, pharmacokinetics, and safety profiles.
  • Discussion of clinical indications and dosing considerations.

Main Results:

  • Diverse antithrombotic classes exist with unique properties.
  • Efficacy and duration depend on indication and patient stability.
  • Pharmacokinetic variability necessitates careful dosing in children.

Conclusions:

  • Understanding agent-specific properties is crucial for safe and effective pediatric use.
  • Individualized treatment approaches are essential for optimal outcomes.
  • Further research may refine antithrombotic strategies in children.